Civica Rx (Civica, Inc.) today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher […]
Irish pharmaceutical company Horizon Therapeutics has received the US Food and Drug Administration (FDA) approval for Tepezza (teprotumumab-trbw) to treat thyroid eye disease (TED). The drug is the first to be approved by the FDA […]
SMi Reports: SMi’s Pharmaceutical Microbiology Conference series will feature an exciting agenda and expert speaker line-up. SMi Group are pleased to host the 3rd Annual Pharmaceutical Microbiology East Coast Conference, taking place in Boston on […]
SMi Reports: Interactive workshop overview for SMi’s 22nd Annual Superbugs & Superdrugs Conference, London in March 2020 SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference will commenceon the 30th and 31st March 2020 and […]
SMi reports: Registration is now open for the Highly Potent Active Pharmaceutical IngredientsConference, which will convene in London on 11th-12th May 2020. SMi Group are pleased to announce that the 4th annual Highly Potent Active […]